ConductScience.org, home

Paper37540134

Discrepant Assessments of Progressive Disease in Clinical Trials between Routine Clinical Reads and Formal RECIST 1.1 Interpretations.

Siegel MJ and 3 others. Radiol Imaging Cancer, 2023. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Discrepant Assessments of Progressive Disease in Clinical Trials between Routine Clinical Reads and Formal RECIST 1.1 Interpretations. Papers, record 37540134. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37540134

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Discrepant Assessments of Progressive Disease in Clinical Trials between Routine Clinical Reads and Formal RECIST 1.1 Interpretations.
PubMed
Journal
Radiol Imaging Cancer
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
1.3
iCite
Revised in PubMed
2024-02-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Siegel MJMarilyn Jhttps://orcid.org/0000-0002-8342-8293
2Ippolito JEJoseph Ehttps://orcid.org/0000-0003-1913-5573
3Wahl RLRichard Lhttps://orcid.org/0000-0002-7306-2590
4Siegel BABarry A

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Humans
Female
Middle Aged
Male
Response Evaluation Criteria in Solid Tumors
Retrospective Studies

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P30 CA091842NCI NIH HHSUnited StatesP30CA091842PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in37540135Do Imaging Core Laboratories Better Predict Progression Over Clinical Interpretations?https://conductscience.org/library/papers/37540135

Source PubMed

Download CSV of comments and corrections

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119097774New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).Eur J Cancer2009https://conductscience.org/library/papers/19097774PubMed
219101138Lessons learned from independent central review.Eur J Cancer2009https://conductscience.org/library/papers/19101138PubMed
324772204Automated tracking of quantitative assessments of tumor burden in clinical trials.Transl Oncol2014https://conductscience.org/library/papers/24772204PubMed
412829678Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response.J Clin Oncol2003https://conductscience.org/library/papers/12829678PubMed
536780606Automatic Classification of Tumor Response From Radiology Reports With Rule-Based Natural Language Processing Integrated Into the Clinical Oncology Workflow.JCO Clin Cancer Inform2023https://conductscience.org/library/papers/36780606PubMed
619875758Influence of an independent review committee on assessment of response rate and progression-free survival in phase III clinical trials.Ann Oncol2010https://conductscience.org/library/papers/19875758PubMed
720033179RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline.Eur Radiol2010https://conductscience.org/library/papers/20033179PubMed
810655437
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.
J Natl Cancer Inst2000https://conductscience.org/library/papers/10655437PubMed
922933974Intra- and inter-observer variability in measurement of target lesions: implication on response evaluation according to RECIST 1.1.Radiol Oncol2012https://conductscience.org/library/papers/22933974PubMed
1035657292Standardized Reporting of Oncologic Response: Making Every Report Count.Radiol Imaging Cancer2022https://conductscience.org/library/papers/35657292PubMed
1128825135Tumor response assessment: comparison between unstructured free text reporting in routine clinical workflow and computer-aided evaluation based on RECIST 1.1 criteria.J Cancer Res Clin Oncol2017https://conductscience.org/library/papers/28825135PubMed
1220397778Interobserver and intraobserver variability in the response evaluation of cancer therapy according to RECIST and WHO-criteria.Acta Oncol2010https://conductscience.org/library/papers/20397778PubMed
1333059819Imaging for Response Assessment in Cancer Clinical Trials.Semin Nucl Med2020https://conductscience.org/library/papers/33059819PubMed
1423932487Inter-observer reproducibility of semi-automatic tumor diameter measurement and volumetric analysis in patients with lung cancer.Lung Cancer2013https://conductscience.org/library/papers/23932487PubMed
1526687017Observer variability in RECIST-based tumour burden measurements: a meta-analysis.Eur J Cancer2016https://conductscience.org/library/papers/26687017PubMed
1630537991Discrepancies of assessments in a RECIST 1.1 phase II clinical trial - association between adjudication rate and variability in images and tumors selection.Cancer Imaging2018https://conductscience.org/library/papers/30537991PubMed
1719095437Individual patient data analysis to assess modifications to the RECIST criteria.Eur J Cancer2009https://conductscience.org/library/papers/19095437PubMed

Download CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42761733Multicenter AI- versus expert-assisted RECIST target lesion measurements in follow-up body CT of patients with cancer.Radiol Adv2026https://conductscience.org/library/papers/42761733PubMed
42733787Setting the standard: empirical benchmarks for case-level site-central discordance in radiographic endpoints in oncology clinical trials.Contemp Clin Trials Commun2026https://conductscience.org/library/papers/42733787PubMed
41649544[Imaging-based response criteria in oncology : Assessment of response to treatment in solid tumors and lymphomas].Radiologie (Heidelb)2026https://conductscience.org/library/papers/41649544PubMed
39543673A call for objectivity: Radiologists' proposed wishlist for response evaluation in solid tumors (RECIST 1.1).Cancer Imaging2024https://conductscience.org/library/papers/39543673PubMed
39123402Imaging-Based Disease Assessment and Management Recommendations: Impact of Multidisciplinary Sarcoma Tumor Board.Cancers (Basel)2024https://conductscience.org/library/papers/39123402PubMed
38473353Tumor Response Evaluation Using iRECIST: Feasibility and Reliability of Manual Versus Software-Assisted Assessments.Cancers (Basel)2024https://conductscience.org/library/papers/38473353PubMed
37995707Artificial Intelligence-powered automatic volume calculation in medical images - available tools, performance and challenges for nuclear medicine.Nuklearmedizin2023https://conductscience.org/library/papers/37995707PubMed
37540135Do Imaging Core Laboratories Better Predict Progression Over Clinical Interpretations?Radiol Imaging Cancer2023https://conductscience.org/library/papers/37540135PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37540134

GET https://conductscience.org/api/papers/v1/37540134/authors